Morgan Stanley analyst Thomas Wrigglesworth upgraded Evonik (EVKIF) to Overweight from Equal Weight with a price target of EUR 18, up from EUR 14.70. The firm adjusted ratings in the European industrial chemicals group, saying disruptions to feedstock supply could increase Asian costs ahead of European costs for commodity chemicals. It favors upstream over downgrade and moved BASF to its top pick.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVKIF: